AAPS Announces 2017 Foundation Fellowship Winners
AAPS has announced the five graduate students awarded with a $10,000 fellowship for their research efforts in global health solutions.
On Sep. 7, 2017, the American Association of Pharmaceutical Scientists (AAPS) Foundation awarded five graduate students each with a $10,000 fellowship. According to AAPS, the students’ fields of discipline include liver fibrosis, breast cancer, and sepsis. The 2017 graduate student fellowship winners are:
Elizabeth Gibson
Vanderbilt University
Novel Naphthyridone/Aminopipiridine-Derived Type I Topoisomerase-Targeted Antibacterials
Akshay Jain
University of Missouri Kansas City
Development of Protein and Peptide Based Delivery System for Targeted Therapy of Liver Fibrosis
Dandan Luo
University of Buffalo
Doxorubicin Encapsulated in Porphyrin-Phospholipid (PoP) Liposomes for Chemophototherapy of Solid Tumors
John Schardt
University of Maryland
Engineered Multivalency for Improved HER3 Downregulation and Cancer Therapy
Yangjie Wei
University of Kansas
Lumazine Synthase as a Nanoplatform for the Development of Ricin-Anthrax Combination Vaccine
Additionally, AAPS will continue to fund the following 2016 fellowships:
Mohd M. Khan
University of Maryland School of Pharmacy, Baltimore
Anti-Sepsis Therapeutics Design using Structure/Function Relationship
Brandon Lucke-Wold
West Virginia University
The Pathologic Mechanisms Associated with Chronic Traumatic Encephalopathy
The AAPS Foundation was formed in Nov. 2013 and provides graduate students and assistant faculty members with the resources needed to continue their research and education. AAPS Foundation K–12 programs also teach students about career opportunities available in the pharmaceutical sciences.
Source: AAPS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Understanding the Variability in Bioburden Test Results in Biomanufacturing
May 7th 2025This article explores the impact of test volume, microbial distribution, and dilution errors on bioburden testing variability. It presents statistical approaches to estimate percentage error and discusses strategies to optimize microbial enumeration techniques in biopharmaceutical quality control.
Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing
May 7th 2025The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.
